Variant report
Variant | esv3491576 |
---|---|
Chromosome Location | chr19:51107362-51109386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000161681 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187749298 | chr19:51107389-51107390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192666278 | chr19:51107426-51107427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185729237 | chr19:51107428-51107429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10421679 | chr19:51107444-51107445 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs530820834 | chr19:51107510-51107511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144875909 | chr19:51107518-51107519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374245317 | chr19:51107521-51107522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114494595 | chr19:51107531-51107532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567256062 | chr19:51107544-51107545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534279847 | chr19:51107547-51107548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2914426 | chr19:51107556-51107557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147932207 | chr19:51107567-51107568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538876413 | chr19:51107651-51107652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73932532 | chr19:51107691-51107692 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs200372017 | chr19:51107716-51107717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557516011 | chr19:51107719-51107720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145527050 | chr19:51107724-51107725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575889676 | chr19:51107777-51107778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75929626 | chr19:51107798-51107799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554920863 | chr19:51107808-51107809 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113640951 | chr19:51107818-51107819 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540600491 | chr19:51107823-51107824 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs71355153 | chr19:51107827-51107828 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs1974814 | chr19:51107861-51107862 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73932535 | chr19:51107897-51107898 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs71355154 | chr19:51107932-51107933 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs530571903 | chr19:51107938-51107939 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542917824 | chr19:51107941-51107942 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188257811 | chr19:51107944-51107945 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528096128 | chr19:51107949-51107950 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546168320 | chr19:51107955-51107956 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs137868984 | chr19:51107971-51107972 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114284558 | chr19:51107972-51107973 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs193169230 | chr19:51107976-51107977 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115562340 | chr19:51107977-51107978 | Flanking Bivalent TSS/Enh Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536407976 | chr19:51108005-51108006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116757959 | chr19:51108008-51108009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12974092 | chr19:51108018-51108019 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs141118755 | chr19:51108023-51108024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113608161 | chr19:51108036-51108037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184682893 | chr19:51108037-51108038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12972194 | chr19:51108038-51108039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12972787 | chr19:51108039-51108040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534218095 | chr19:51108052-51108053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558980524 | chr19:51108056-51108057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73932537 | chr19:51108071-51108072 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs113083997 | chr19:51108100-51108101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556341925 | chr19:51108128-51108129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575411899 | chr19:51108135-51108136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542429296 | chr19:51108143-51108144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17160897 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51106800-51109000 | Weak transcription | K562 | blood |
2 | chr19:51107800-51108000 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
3 | chr19:51107800-51109800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr19:51109000-51109200 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
5 | chr19:51109000-51109200 | Enhancers | Brain Inferior Temporal Lobe | brain |
6 | chr19:51109000-51109400 | Bivalent/Poised TSS | H1 Cell Line | embryonic stem cell |
7 | chr19:51109000-51109400 | Bivalent/Poised TSS | HUES6 Cell Line | embryonic stem cell |
8 | chr19:51109000-51109400 | Enhancers | Brain Angular Gyrus | brain |
9 | chr19:51109000-51109400 | Bivalent/Poised TSS | A549 | lung |
10 | chr19:51109000-51109400 | Flanking Active TSS | K562 | blood |
11 | chr19:51109000-51109800 | Active TSS | Brain Substantia Nigra | brain |
12 | chr19:51109000-51110800 | Active TSS | Brain Anterior Caudate | brain |
13 | chr19:51109000-51110800 | Enhancers | Brain Hippocampus Middle | brain |
14 | chr19:51109200-51109400 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
15 | chr19:51109200-51109400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr19:51109200-51109400 | Flanking Bivalent TSS/Enh | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr19:51109200-51109400 | Flanking Active TSS | Brain Cingulate Gyrus | brain |
18 | chr19:51109200-51109400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
19 | chr19:51109200-51109400 | Bivalent Enhancer | Placenta | Placenta |
20 | chr19:51109200-51109800 | Active TSS | Brain Inferior Temporal Lobe | brain |